| __timestamp | Blueprint Medicines Corporation | Xencor, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 31844000 | 18516000 |
| Thursday, January 1, 2015 | 48588000 | 34140000 |
| Friday, January 1, 2016 | 81131000 | 51872000 |
| Sunday, January 1, 2017 | 144687000 | 71772000 |
| Monday, January 1, 2018 | 243621000 | 97501000 |
| Tuesday, January 1, 2019 | 331450000 | 118590000 |
| Wednesday, January 1, 2020 | 326860000 | 169802000 |
| Friday, January 1, 2021 | 601033000 | 192507000 |
| Saturday, January 1, 2022 | 477419000 | 199563000 |
| Sunday, January 1, 2023 | 427720000 | 253598000 |
| Monday, January 1, 2024 | 341433000 |
Unleashing the power of data
In the competitive world of biotechnology, innovation is the lifeblood of success. Blueprint Medicines Corporation and Xencor, Inc. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. Since 2014, Blueprint Medicines has consistently outpaced Xencor in R&D spending, with a peak investment in 2021 that was nearly three times higher than Xencor's. This trend highlights Blueprint's aggressive strategy to lead in drug discovery and development. However, Xencor has shown a steady increase in its R&D budget, growing by over 1,200% from 2014 to 2023. As both companies continue to innovate, their commitment to R&D underscores the critical role of investment in shaping the future of biotechnology.
AstraZeneca PLC or Xencor, Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Gilead Sciences, Inc. vs Blueprint Medicines Corporation
Who Prioritizes Innovation? R&D Spending Compared for Gilead Sciences, Inc. and Xencor, Inc.
Comparing Innovation Spending: Regeneron Pharmaceuticals, Inc. and Xencor, Inc.
Alnylam Pharmaceuticals, Inc. vs Blueprint Medicines Corporation: Strategic Focus on R&D Spending
Research and Development: Comparing Key Metrics for Blueprint Medicines Corporation and ImmunityBio, Inc.
Blueprint Medicines Corporation vs Ligand Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Blueprint Medicines Corporation and Mesoblast Limited
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs Xencor, Inc.
Comparing Innovation Spending: Amneal Pharmaceuticals, Inc. and Xencor, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Xencor, Inc.
Ligand Pharmaceuticals Incorporated vs Xencor, Inc.: Strategic Focus on R&D Spending